Millian, Craig

Insider profile

Performance

Overall performance
0.8

Performance over holding periods
0.8
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Millian, Craig's trades of HLS Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
120.58
Quantity 18,720 +17.2%
Value US$3,703,624
Transaction date
Purchase
Price
451.50
Quantity 84,169 -37.3%
Value US$1,310,100
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-17 2026-06-17 B Purchase
18,720 +17.2%
120.58
US$3,703,624
18,720 +17.2% 120.58 US$3,703,624
2024-05-16 2024-05-15 B Purchase
84,169 -37.3%
451.50
US$1,310,100
84,169 -37.3% 451.50 US$1,310,100